Results of a pilot trial
show that Intersect ENT Inc.’s steroid-releasing S8 sinus implant may significantly reduce symptoms of chronic sinusitis and may offer a less invasive alternative to second surgery for patients who suffer recurrent disease refractory to medical therapy after sinus surgery
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?